176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
102.27%
Some net income increase while MRVL is negative at -12.86%. John Neff would see a short-term edge over the struggling competitor.
-1.03%
Both reduce yoy D&A, with MRVL at -14.93%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-116.41%
Negative yoy deferred tax while MRVL stands at 310.76%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
0.76%
Less SBC growth vs. MRVL's 5.88%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
423.03%
Slight usage while MRVL is negative at -228.51%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
1608.83%
AR growth while MRVL is negative at -62.38%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-41.79%
Both reduce yoy inventory, with MRVL at -243.38%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-205.04%
Negative yoy AP while MRVL is 38.37%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
407.85%
Some yoy usage while MRVL is negative at -151.01%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-3664.96%
Both negative yoy, with MRVL at -156.63%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
104.86%
Some CFO growth while MRVL is negative at -31.82%. John Neff would note a short-term liquidity lead over the competitor.
2.20%
Some CapEx rise while MRVL is negative at -25.51%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-20.26%
Negative yoy purchasing while MRVL stands at 23.03%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-19.17%
Both yoy lines are negative, with MRVL at -39.81%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-287.02%
We reduce yoy other investing while MRVL is 100.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-88.59%
Both yoy lines negative, with MRVL at -650.44%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-190.70%
Both yoy lines negative, with MRVL at -2.04%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
178.34%
Stock issuance far above MRVL's 297.07%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.